Venetoclax and azacitidine was found safe, but further randomized trials are needed to determine the full extent of the combination’s efficacy in myelodysplastic syndromes (MDS) and acute myeloid ...
One cancer drug shortage has ended and at least 14 oncology drugs are in short supply, according to the FDA, the American Society of Health-System Pharmacists and physicians. Azacitidine injections: ...
Please provide your email address to receive an email when new articles are posted on . A 5-day azacitidine course had the most consistent survival benefit for low-risk MDS vs. other shorter ...
These drugs are the latest in a growing list of oncology medications in short supply: Azacitidine injections: Three drugmakers stopped making 100 milligram solutions of the leukemia drug. Iobenguane I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results